Dr. Parry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215Phone+1 617-632-3000
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2016 - 2020
- Johns Hopkins UniversityResidency, Internal Medicine, 2013 - 2016
- Johns Hopkins University School of MedicineClass of 2013
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MA State Medical License 2016 - 2026
- VT State Medical License 2022 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma.Andrew Looka, David A Qualls, Daniel Matthews, Robert A Redd, Christopher Sakellis
Blood Advances. 2025-02-11 - 6 citationsAnti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.Adam S Kittai, David Bond, Ying Huang, Seema A Bhat, Emily Blyth
Journal of Clinical Oncology. 2024-06-10 - 5 citationsA multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia.Paul J Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger
Blood Advances. 2024-05-28
Press Mentions
- Mapping Genetic Evolution from CLL to Richter’s SyndromeJanuary 10th, 2023
- Scientists Map Genetic Evolution of Chronic Lymphocytic Leukemia to Richter’s SyndromeDecember 11th, 2022
- Advances in Malignant Lymphoma: Discoveries from Precursors to ProgressionJune 20th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: